306997
Altruism reasons for disclosure, partner relationship quality, and impacts of HIV disclosure
Method: A total of 2,987 PLH was recruited from 12 cities/counties in Guangxi, China to participate in a self-administered cross-sectional survey. Participants who had disclosed their HIV status to stable sexual partners (n=986) were further asked about questions related to HIV disclosure. We categorized this sample as three groups (low, medium, and high) based on their scores of relationship quality with stable partners. Descriptive analysis was used to demonstrate the level of agreement with altruism reasons. One-way ANOVA and multivariate regressions were used to explore association between variables of interests.
Results: The level of agreement with altruism reasons was higher in the group of higher relationship quality (F(986 2)=33.29, p<.001). Participants who expressed higher level of agreement with altruism reasons for disclosure were more likely to perceive positive consequence of disclosure (B =.728, 95%CI [.697, .759, p<.001), report positive impacts of disclosure (B =.335, 95%CI [.235, .434], p<.001), and report not regretting about disclosing to partners (OR =1.752, 95%CI [1.136, 2.702], p=.011).
Discussion: Our findings suggest altruism reasons for disclosure were associated with better relationship quality and positive impacts of partner HIV disclosure. Future HIV disclosure intervention may take efforts to improve partner relationship quality and promote altruism perceptions on disclosure.
Learning Areas:
Protection of the public in relation to communicable diseases including prevention or controlPublic health or related research
Social and behavioral sciences
Learning Objectives:
Demonstrate the relationship between altruism reasons for disclosure,partner relationship quality, and disclosure impacts
Keyword(s): HIV/AIDS, Partner Involvement
Qualified on the content I am responsible for because: I conducted data analysis and prepared the abstract.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.